|
|
 |
|
Viewing report
|
|
|
|
Personalized Medicine
TriMark Publications, Aug 2007, Pages: 87
Personalized medicine and pharmacogenomics are inextricably linked. Pharmacogenomics is the use of genetic variations (such as SNPs, gene expression variability, or other molecular signatures) to understand and correlate with differential response to pharmaceutical agents (drugs). Pharmacogenomics can be deployed clinically to stratify patients into responders and non-responders and this practice is termed personalized medicine.
The purpose of this report is to describe the specific market segment of the diagnostics market called personalized medicine. To frame the context of current approaches, pharmacogenomics seeks to identify and validate the signature(s) of molecular analytes and these are converted to assays using the tools of molecular diagnostics. The deployment of these molecular diagnostics assays on defining and targeting patient populations is the domain of personalized medicine.
This study includes all of the generally-accepted imaging activities that are currently used in personalized medicine, including pharmacogenomics, genomics and theranostics. It examines associated clinical market segments in which personalized medicine has taken a prominent role including cancer treatment, cardiology and neurology markets.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Also available
DNA Sequencing and PCR Markets
Microarray Markets
Bioinformatics Markets
Gene Expression Reagents Markets
RNA Interference Markets
Genomics World Markets 2008
Genetics Bundle
Customers who bought this item also bought
Companion Diagnostics in Personalized Medicine and Cancer Therapy
Personalized Medicine - Scientific and Commercial Aspects
Cancer Personalized Medicine 2008
The Role of Pharmacogenomics in Personalized Medicine
Dealmaking and Business Strategies in the Age of Personalized Medicine
MicroRNA Diagnostics, Therapeutics, and Cancer Personalized Medicine 2009 Market Report
The Trend Toward Personalized Medicine
Personalized Medicine: The Impact of Pharmacogenomics on Pharmaceutical R&D and Sales
How to Integrate Personalized Medicine into Business Strategies
Innovations in Diagnostics: Next Generation Molecular and Point-of-Care Diagnostics Driving Personalized Healthcare
The Future of Personalized Medicine: The Impact of Proteomics on Drug Discovery And Clinical Trial Design
Nucleic Acid Testing: A Vehicle for Advancing Personalized Medicine
|
|
|
|
